Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial

BACKGROUND: The New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial vs. ASA to Prevent Embolism in Embolic Stroke of Undetermined Source (NAVIGATE-ESUS) trial is a randomized phase-III trial comparing rivaroxaban versus aspirin in patients with recent ESUS. AIMS: We aimed to describe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Stroke Cerebrovasc Dis
Main Authors: Kasner, Scott E., Lavados, Pablo, Sharma, Mukul, Wang, Yongjun, Wang, Yilong, Dávalos, Antoni, Shamalov, Nikolay, Cunha, Luis, Lindgren, Arne, Mikulik, Robert, Arauz, Antonio, Lang, Wilfried, Czlonkowska, Anna, Eckstein, Jens, Gagliardi, Rubens, Amarenco, Pierre, Ameriso, Sebastián F., Tatlisumak, Turgut, Veltkamp, Roland, Hankey, Graeme J., Toni, Danilo S., Bereczki, Daniel, Uchiyama, Shinichiro, Ntaios, George, Yoon, Byung-Woo, Brouns, Raf, DeVries Basson, M.M., Endres, Matthias, Muir, Keith, Bornstein, Natan, Ozturk, Serefnur, O’Donnell, Martin, Mundl, Hardi, Pater, Calin, Weitz, Jeffrey, Peacock, W. Frank, Swaminathan, Balakumar, Kirsch, Bodo, Berkowitz, Scott D., Peters, Gary, Pare, Guillaume, Themeles, Ellison, Shoamanesh, Ashkan, Connolly, Stuart J., Hart, Robert G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701183/
https://ncbi.nlm.nih.gov/pubmed/29525076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados